Drug details

Obizur (antihemophilic factor (recombinant), porcine sequence] powder for intravenous injection)

type of Hemostatics, Coagulation Factors

Obizur [antihemophilic factor (recombinant), porcine sequence] is a recombinant DNA derived, antihemophilic factor indicated for the treatment of bleeding episodes in adults with acquired hemophilia A.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• itching,
• rash,
• dizziness,
• wheezing,
• red, swollen, blistered, or peeling skin with or without fever,
• tightness in the chest or throat,
• unusual hoarseness,
• shortness of breath
• trouble swallowing or talking,
• fainting, and

The following drugs are related to Obizur, either as a replacement or used together:

• Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
• Alprolix ([coagulation factor ix (recombinant), fc fusion protein], lyophilized powder for solution for intravenous injection)
• Altuviiio (antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl)
• Kogenate FS (antihemophilic factor (recombinant))
• Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
• Coagadex (coagulation factor x lyophilized powder)
• Rixubis (coagulation factor ix (recombinant) for intramuscular injection)
• Sevenfact (coagulation factor viia (recombinant)-jncw for injection)
• Stimate (desmopressin acetate nasal spray)
• Ixinity ([coagulation factor ix (recombinant)] for injection)